Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.
Integrated multi-cohort transcriptional meta-analysis of neurodegenerative diseases.
Lack of replication of interaction between EBNA1 IgG and smoking in risk for multiple sclerosis.
African ancestry is a predictor factor to secondary progression in clinical course of multiple sclerosis.
Topography of brain sodium accumulation in progressive multiple sclerosis.
Spatial reference memory deficits precede motor dysfunction in an experimental autoimmune encephalomyelitis model: The role of kallikrein-kinin system.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
A cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod.
Lessons Learned From Fatal Progressive Multifocal Leukoencephalopathy in a Patient With Multiple Sclerosis Treated With Natalizumab.
Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.
Reading, writing, and reserve: Literacy activities are linked to hippocampal volume and memory in multiple sclerosis.
T cell responses after hematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis.
Moving to Fingolimod From Natalizumab in Multiple Sclerosis: The ENIGM Is Not Solved.
Effect of comorbidity on mortality in multiple sclerosis.
Current understanding on the role of standard and immunoproteasomes in inflammatory/immunological pathways of multiple sclerosis.
Pragmatic exercise intervention for people with multiple sclerosis (ExIMS Trial): Study protocol for a randomised controlled trial.
Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
Diffusional kurtosis imaging of normal-appearing white matter in multiple sclerosis: preliminary clinical experience.
Perceived cognitive decline in multiple sclerosis impacts quality of life independently of depression.
JNK inhibitors as anti-inflammatory and neuroprotective agents.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Early detection and favourable outcome of natalizumab-related progressive multifocal leukoencephalopathy (PML) in two multiple sclerosis patients.
Intermediate uveitis in children and young adults: differences in clinical course, associations and visual outcome.
Bilateral optic neuritis after inactivated influenza vaccination.

Pages